Consonance Capital Management as of Dec. 31, 2014
Portfolio Holdings for Consonance Capital Management
Consonance Capital Management holds 24 positions in its portfolio as reported in the December 2014 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Enanta Pharmaceuticals (ENTA) | 11.1 | $86M | 1.7M | 50.85 | |
| United Therapeutics Corporation (UTHR) | 11.0 | $86M | 660k | 129.49 | |
| Cardiovascular Systems | 8.3 | $64M | 2.1M | 30.08 | |
| Biosante Pharmaceuticals (ANIP) | 7.9 | $62M | 1.1M | 56.39 | |
| Akorn | 7.8 | $61M | 1.7M | 36.20 | |
| Insys Therapeutics | 6.8 | $53M | 1.3M | 42.16 | |
| Anacor Pharmaceuticals In | 6.1 | $47M | 1.5M | 32.25 | |
| Abbvie (ABBV) | 5.8 | $45M | 688k | 65.44 | |
| Orthofix International Nv Com Stk | 5.6 | $43M | 1.4M | 30.06 | |
| Pernix Therapeutics Holdings | 4.2 | $32M | 3.4M | 9.39 | |
| Retrophin | 4.0 | $31M | 2.6M | 12.24 | |
| Hyperion Therapeutics | 3.9 | $30M | 1.3M | 24.00 | |
| Osiris Therapeutics | 3.5 | $27M | 1.7M | 15.99 | |
| Healthways | 3.4 | $26M | 1.3M | 19.88 | |
| Derma Sciences | 2.0 | $15M | 1.6M | 9.31 | |
| Adma Biologics (ADMA) | 1.3 | $9.8M | 877k | 11.17 | |
| HealthStream (HSTM) | 1.2 | $9.5M | 321k | 29.48 | |
| Protalix BioTherapeutics | 1.2 | $9.3M | 5.1M | 1.84 | |
| Everyday Health | 1.2 | $9.3M | 633k | 14.75 | |
| BioScrip | 1.1 | $8.2M | 1.2M | 6.99 | |
| Vericel (VCEL) | 0.9 | $7.2M | 2.4M | 3.04 | |
| HMS Holdings | 0.8 | $6.3M | 299k | 21.14 | |
| BioTime | 0.8 | $6.0M | 1.6M | 3.73 | |
| Merus Labs Intl | 0.3 | $2.2M | 1.4M | 1.65 |
